Kannapiran Ponraj

Dr. Kannapiran Ponraj

Chemistry, Washington State University, Pullman, Washington, USA
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2008 in Archives of Biochemistry and Biophysics
Verified
Journal Article
Closed access
RMRaj Kumar Mandraju
Raj Kumar Mandraju
Kannapiran PonrajKannapiran Ponraj
Kannapiran Ponraj
AKAnand K. Kondapi
Anand K. Kondapi

31 January 2025 in Journal of Xenobiotics
Verified
Journal Article
Open access
PDF file
KGKari Ann Gaither
Kari Ann Gaither
EYEileen Yue
Eileen Yue
DSDilip Kumar Singh
Dilip Kumar Singh
JTJulia Trudeau
Julia Trudeau
Kannapiran PonrajKannapiran Ponraj
Kannapiran Ponraj
BPBhagwat Prasad
Bhagwat Prasad
In this study, to better understand the mechanisms of the profound impact of alcohol consumption on drug pharmacokinetics, efficacy, and toxicity, we characterized the alcohol-induced changes in the ensemble of drug-metabolizing enzymes and transporters (DMETs) in the human liver by performing global proteomic analysis of human liver microsomes from 94 donors. DMET protein levels were analyzed concerning alcohol consumption, smoking history, and sex using non-parametric tests, which were further strengthened by correlational analysis. To this end, we used a provisional index of alcohol exposure formulated based on the relative abundances of four marker proteins best correlating with the level of alcohol consumption. Alcohol-induced changes in the cytochrome P450 pool include significant increases in CYP2E1, CYP2B6, CYP2J2, and NADPH-cytochrome P450 reductase levels and the lowering of CYP1A2, CYP2C8, CYP2C9, CYP4A11, and cytochrome b5. Changes in UDP-glucuronosyltransferase (UGT) abundances comprise elevated UGT1A6, UGT1A9, and UGT2A1, and reduced UGT1A3, UGT1A4, UGT2B7, UGT2B10, and UGT2B15 levels. Tobacco smokers showed elevated CYP1A2, UGT1A6, and UGT2B4 and reduced FMO3, FMO4, and FMO5 levels, while in females, CYP1A2, UGT2B17, and UGT2B15 levels were lower, and UGT2A3 and STS were higher compared to males. The alcohol-induced changes in the DMET ensemble at the protein level reported herein provide deep insights into how alcohol impacts drug and xenobiotic metabolism.

29 December 2021 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
BDBhaba Krishna Das
Bhaba Krishna Das
AKAmit Kumar
Amit Kumar
SSSreeshma Nellootil Sreekumar
Sreeshma Nellootil Sreekumar
Kannapiran PonrajKannapiran Ponraj
Kannapiran Ponraj
KGKaustubh Gadave
Kaustubh Gadave
AAArulandu Arockiasamy
Arulandu Arockiasamy

22 June 2022 in Journal of Microbiology
Verified
Journal Article
Closed access
PDF file
MSMuthusaravanan Sivaramakrishnan
Muthusaravanan Sivaramakrishnan
RSRahul Suresh
Rahul Suresh
Kannapiran PonrajKannapiran Ponraj
Kannapiran Ponraj
Bacteria exist in natural environments for most of their life as complex, heterogeneous, and multicellular aggregates. Under these circumstances, critical cell functions are controlled by several signaling molecules known as quorum sensing (QS) molecules. In Gram-positive bacteria, peptides are deployed as QS molecules. The development of antibodies against such QS molecules has been identified as a promising therapeutic intervention for bacterial control. Hence, the identification of QS peptides has received considerable attention. Availability of a fast and reliable predictive model to effectively identify QS peptides can help the existing high throughput experiments. In this study, a stacked generalization ensemble model with Gradient Boosting Machine (GBM)-based feature selection, namely EnsembleQS was developed to predict QS peptides with high accuracy. On selected GBM features (791D), the EnsembleQS outperformed finely tuned baseline classifiers and demonstrated robust performance, indicating the superiority of the model. The accuracy of EnsembleQS is 4% higher than those resulting from ensemble model on hybrid dataset. When evaluating an independent data set of 40 QS peptides, the EnsembleQS model showed an accuracy of 93.4% with Matthew’s Correlation Coefficient (MCC) and area under the ROC curve (AUC) values of 0.91 and 0.951, respectively. These results suggest that EnsembleQS will be a useful computational framework for predicting QS peptides and will efficiently support proteomics research. The source code and all datasets used in this study are publicly available at https://github.com/proteinexplorers/EnsembleQS.

10 October 2024 in Biochemical Pharmacology
Verified
Journal Article
Closed access
Kannapiran PonrajKannapiran Ponraj
Kannapiran Ponraj
KGKari A. Gaither
Kari A. Gaither
DSDilip Kumar Singh
Dilip Kumar Singh
NDNadezhda Davydova
Nadezhda Davydova
MZMengqi Zhao
Mengqi Zhao
Dmitri DavydovDmitri Davydov
Dmitri Davydov

1 June 2013 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
Kannapiran PonrajKannapiran Ponraj
Kannapiran Ponraj
MPMaddela Prabhakar
Maddela Prabhakar
RRRS Rathore
RS Rathore
ABAkhila Bommakanti
Akhila Bommakanti
AKAnand K. Kondapi
Anand K. Kondapi
Viruses have been found to exhibit protein kinase activity associated with their purified viral particles. HIV-1 virus particles possess a novel 72 kD protein, Topoisomerase II beta kinase (Topo IIβKHIV) activity. The enzyme, isolated and purified from PEGprecipitated HIV-1 particles, is insensitive against a diverse set of known kinase inhibitors. The pyridine derivatives were found to be active against both Topo IIβKHIV activity and HIV-1 replication. For both kinase antagonism and anti-HIV-1 activity the Comparative Molecular Field Analysis (CoMFA) models were proposed. The CoMFA model was also evaluated independently with a set of test molecules for their anti-viral activity. The kinase inhibition and anti-viral activities for these inhibitors, tested in an in vitro kinase agree with the CoMFA model (cross-validated r2 (q2) value of 0.642 with six principal components), lower acceptable results are obtained with anti- HIV-1 activity (cross-validated r2 (q2) value of 0.358 with four principal components) and also correlate with relative solvation free energy calculations. The predictive power of the models was evaluated with 2 test molecules each and tends to lie within 1 log unit. An in cell validation of the model with a representative inhibitor, 2-methoxypyridine shows its ability to inhibit Topo IIβ phosphorylation during acute HIV-1 infection. Close correlation of molecular fields of inhibitory domains of kinase and HIV-1 inhibitors suggests specificity of action of pyridine derivatives in affecting HIV-1 replication through inhibition of Kinase activity. These investigations suggest that Topo IIβKHIV is a potential target for an effective control of HIV-1 replication that would help in developing new anti-retroviral molecules.